The portable breast cancer screening test, which runs on Pandora CDx technology, uses a simple drop of blood to generate results in 15 minutes
POC Medical Systems has unveiled a rapid, portable breast cancer screening test, MammoAlert based on its Pandora CDx microfluidics-based platform. The blood-based test will be launched initially in India where established screening methods are not widely accessible to large populations of women. The test is the first application of the company’s platform.
The Pandora CDx developed by POC Medical Systems is a microfluidic platform for rapid, point-of-care serum screening. It is based on a unique, low cost disposable microfluidic disk. The platform is a simple and easy-to-use system. This portable breast cancer screening test, which runs on Pandora CDx technology, uses a simple drop of blood to generate results in 15 minutes. It uses multiple cancer markers for high accuracy. The Pandora CDx has a sensitivity of 0.97 and specificity of 1 which implies an accuracy of over 95 per cent and a false positive rate of zero. This will have a huge social impact enabling thousands of women in India to detect breast cancer in its early stage due to the products efficient, simple, accurate and significant affordability.
Present on the occasion were Amruta Fadnavis, Dr Deepak Sawant, Health Minister, Maharashtra, Prakash Mehta, Minister of Housing Department, Maharashtra and Sunil Oza, Sahaprabhari, Uttar Pradesh were present for the global unveiling.
Comments are closed.